Department of Public Health, Faculty of Medicine and Pharmaceutical Sciences, Douala University, Douala, Cameroon.
Department of Internal Medicine and Specialties, Faculty of Medicine and Sciences Pharmaceutical of the University of Dschang, Dschang, Cameroon.
Pan Afr Med J. 2024 Apr 9;47:174. doi: 10.11604/pamj.2024.47.174.41677. eCollection 2024.
phytotherapy is widely used in Africa for the management of many diseases. Data on the use of phytotherapy in people with type 2 diabetes are scarce. We aimed to determine the frequency and factors associated with the consumption/use of phytotherapy products among patients with type 2 diabetes in the Dschang Health District.
we conducted a cross-sectional study from January to May 2022, including community-dwelling or hospitalized patients with type 2 diabetes who had lived in the Dschang Health District for at least one year. Informed consent was obtained from all patients. Data were collected using a pre-designed questionnaire. Variables collected included socio-demographic characteristics, diabetes knowledge and practices, and perceptions of care.
we included 403 (249 women) patients with type 2 diabetes with a mean (SD) age of 63 (± 14.86) years). Among them, 240 (59.55%) used phytotherapy, either in combination with conventional treatment (168 (41.69%) participants) or not (72 (17.86%) participants), to treat diabetes. The most common reasons for using phytotherapy were easy accessibility and belief in its efficacy. Most patients used both treatments because they thought the combination was more effective. In univariable analysis, we observed a statistically significant association between level of education (p=0.003), socioeconomic level (p<0.001), place of residence (p=0.003), duration of diabetes (p=0.007), and use of phytotherapy. In multivariable analysis, only age between 51 and 60 years (OR: 0.50, 95% CI 0.298 - 0.8521; p=0.01) was associated with the use of phytotherapy.
people living with T2D in the Dschang Health District frequently use phytotherapy as an antidiabetic remedy, especially those aged between 51 and 60 years, those with low education level, low socioeconomic level and medium duration of diabetes. There is a need to evaluate its effectiveness in treating diabetes and its adverse effects.
在非洲，草药疗法被广泛用于治疗许多疾病。关于 2 型糖尿病患者使用草药疗法的数据很少。我们旨在确定 2 型糖尿病患者在 Dschang 卫生区使用/使用草药疗法产品的频率和相关因素。
我们于 2022 年 1 月至 5 月进行了一项横断面研究，包括在 Dschang 卫生区居住至少一年的社区居住或住院的 2 型糖尿病患者。所有患者均获得知情同意。使用预先设计的问卷收集数据。收集的变量包括社会人口统计学特征、糖尿病知识和实践以及护理认知。
我们纳入了 403 名（249 名女性）2 型糖尿病患者，平均（SD）年龄为 63（±14.86）岁）。其中，240 名（59.55%）患者使用草药疗法，或与常规治疗联合使用（168 名（41.69%）参与者）或不联合使用（72 名（17.86%）参与者）治疗糖尿病。使用草药疗法的最常见原因是容易获得和相信其疗效。大多数患者使用两种治疗方法，因为他们认为联合治疗更有效。在单变量分析中，我们观察到教育水平（p=0.003）、社会经济水平（p<0.001）、居住地（p=0.003）、糖尿病持续时间（p=0.007）和使用草药疗法之间存在统计学显著关联。在多变量分析中，只有 51 至 60 岁之间的年龄（OR：0.50，95%CI 0.298-0.8521；p=0.01）与使用草药疗法相关。
Dschang 卫生区的 2 型糖尿病患者经常使用草药疗法作为抗糖尿病药物，尤其是 51 至 60 岁之间的患者、教育水平低、社会经济水平低和糖尿病持续时间中等的患者。有必要评估其治疗糖尿病的有效性及其不良反应。
